Cargando…
Design and development of hydrogel nanoparticles for mercaptopurine
Hydrogel nanoparticles have gained attention in recent years as they demonstrate the features and characters of hydrogels and nanoparticles at the same time. In the present study chitosan and carrageenan have been used, as hydrogel nanoparticles of mercaptopurine are developed using natural, biodegr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255408/ https://www.ncbi.nlm.nih.gov/pubmed/22247867 http://dx.doi.org/10.4103/0110-5558.72431 |
_version_ | 1782220995534258176 |
---|---|
author | Senthil, V. Kumar, R. Suresh Nagaraju, C. V. V. Jawahar, N. Ganesh, G. N. K. Gowthamarajan, K. |
author_facet | Senthil, V. Kumar, R. Suresh Nagaraju, C. V. V. Jawahar, N. Ganesh, G. N. K. Gowthamarajan, K. |
author_sort | Senthil, V. |
collection | PubMed |
description | Hydrogel nanoparticles have gained attention in recent years as they demonstrate the features and characters of hydrogels and nanoparticles at the same time. In the present study chitosan and carrageenan have been used, as hydrogel nanoparticles of mercaptopurine are developed using natural, biodegradable, and biocompatible polymers like chitosan and carrageenan. As these polymers are hydrophilic in nature, the particles will have a long life span in systemic circulation. Hydrogel nanoparticles with mercaptopurine is form an antileukemia drug by the counter polymer gelation method. Fourier-Transform Infrared (FT-IR) studies have shown a compatibility of polymers with the drug. The diameter of hydrogel nanoparticles was about 370 – 800 nm with a positive zeta potential of 26 – 30 mV. The hydrogel nanoparticles were almost spherical in shape, as revealed by scanning electron microscopy (SEM). Drug loading varied from 9 to 17%. Mercaptopurine released from the nanoparticles at the end of the twenty-fourth hour was about 69.48 – 76.52% at pH 7.4. The drug release from the formulation was following zero order kinetics, which was evident from the release kinetic studies and the mechanism of drug release was anomalous diffusion, which indicated that the drug release was controlled by more than one process. |
format | Online Article Text |
id | pubmed-3255408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-32554082012-01-13 Design and development of hydrogel nanoparticles for mercaptopurine Senthil, V. Kumar, R. Suresh Nagaraju, C. V. V. Jawahar, N. Ganesh, G. N. K. Gowthamarajan, K. J Adv Pharm Technol Res Original Article Hydrogel nanoparticles have gained attention in recent years as they demonstrate the features and characters of hydrogels and nanoparticles at the same time. In the present study chitosan and carrageenan have been used, as hydrogel nanoparticles of mercaptopurine are developed using natural, biodegradable, and biocompatible polymers like chitosan and carrageenan. As these polymers are hydrophilic in nature, the particles will have a long life span in systemic circulation. Hydrogel nanoparticles with mercaptopurine is form an antileukemia drug by the counter polymer gelation method. Fourier-Transform Infrared (FT-IR) studies have shown a compatibility of polymers with the drug. The diameter of hydrogel nanoparticles was about 370 – 800 nm with a positive zeta potential of 26 – 30 mV. The hydrogel nanoparticles were almost spherical in shape, as revealed by scanning electron microscopy (SEM). Drug loading varied from 9 to 17%. Mercaptopurine released from the nanoparticles at the end of the twenty-fourth hour was about 69.48 – 76.52% at pH 7.4. The drug release from the formulation was following zero order kinetics, which was evident from the release kinetic studies and the mechanism of drug release was anomalous diffusion, which indicated that the drug release was controlled by more than one process. Medknow Publications & Media Pvt Ltd 2010 /pmc/articles/PMC3255408/ /pubmed/22247867 http://dx.doi.org/10.4103/0110-5558.72431 Text en Copyright: © Journal of Advanced Pharmaceutical Technology & Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Senthil, V. Kumar, R. Suresh Nagaraju, C. V. V. Jawahar, N. Ganesh, G. N. K. Gowthamarajan, K. Design and development of hydrogel nanoparticles for mercaptopurine |
title | Design and development of hydrogel nanoparticles for mercaptopurine |
title_full | Design and development of hydrogel nanoparticles for mercaptopurine |
title_fullStr | Design and development of hydrogel nanoparticles for mercaptopurine |
title_full_unstemmed | Design and development of hydrogel nanoparticles for mercaptopurine |
title_short | Design and development of hydrogel nanoparticles for mercaptopurine |
title_sort | design and development of hydrogel nanoparticles for mercaptopurine |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255408/ https://www.ncbi.nlm.nih.gov/pubmed/22247867 http://dx.doi.org/10.4103/0110-5558.72431 |
work_keys_str_mv | AT senthilv designanddevelopmentofhydrogelnanoparticlesformercaptopurine AT kumarrsuresh designanddevelopmentofhydrogelnanoparticlesformercaptopurine AT nagarajucvv designanddevelopmentofhydrogelnanoparticlesformercaptopurine AT jawaharn designanddevelopmentofhydrogelnanoparticlesformercaptopurine AT ganeshgnk designanddevelopmentofhydrogelnanoparticlesformercaptopurine AT gowthamarajank designanddevelopmentofhydrogelnanoparticlesformercaptopurine |